Annual Report and AGM Notice submitted for FY 2025-26

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.3%Reaction day

₹4.82

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-3.3%+6.6% vs market

Healthcare Service Provider peers, median of 25sector-0.6%+3.9% vs sector

On the reaction day the stock moved 6.6 pts more than Nifty Microcap 250 and 3.9 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.3-3.3+6.6-0.6+3.9

Next day

+12.9-3.4+16.3-0.6+13.5

+24.1-2.6+26.6+0.2+23.9

+36.3-1.0+37.3-0.7+37.0

+42.9-1.2+44.1-0.4+43.3

+50.0-0.7+50.7-0.4+50.4

+65.1-1.0+66.1-0.1+65.3

15d

+107.9-1.7+109.6-5.6+113.5

+114.5-4.1+118.6-6.4+120.9

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Boston Commerce Limited (formerly Boston Bio Systems) submitted its 31st Annual Report for FY 2025-26 to BSE. The 31st AGM is scheduled for September 30, 2026 at 5 PM via video conferencing. Items include adopting audited financials, appointing new Co-Statutory Auditors Nirav S Shah and Company for a 5-year term, and regularising appointment of new Whole-Time Director and CFO Archana Pandya.

Likely market impact

Routine annual filing. Management reshuffle after MD and previous CFO resigned mid-year. New auditors proposed.